Live
- CM discusses modalities with Union ministers
- Civic body to give boost to SHG group products
- Union Bank of India celebrates foundation day
- Thanks to Centre, AP on fast-track mode
- First Impressions and Unboxing of the MacBook Pro M4: A Powerhouse for Professionals and Creators
- China Gears Up for Potential Trade War Amid Trump’s Tariff Threats
- Small Farmers Gain Less by Selling to Supermarkets: Study Reveals
- Why Despite the Controversy, America Is Anticipating the Mike Tyson vs. Jake Paul Fight
- Sanju Samson and Tilak Varma Shine: Record-Breaking Feats in 4th T20I Against South Africa
- India Urges $1.3 Trillion Annual Climate Support for Developing Nations
Premium stent comes to town!
MicroPort’sthird generation technology, ‘Target Eluting Stent’ (TES) was launched in the city on Friday. TES, which helps coronary arteries of patients heal faster with fewer polymersand less drug load, post angioplasty, ensures a low risk of re-blockage (restenosis) and blood clotting (thrombosis).
MicroPort’sthird generation technology, ‘Target Eluting Stent’ (TES) was launched in the city on Friday. TES, which helps coronary arteries of patients heal faster with fewer polymersand less drug load, post angioplasty, ensures a low risk of re-blockage (restenosis) and blood clotting (thrombosis).
Commenting on the launch, Dr Riyaz Desai, the Managing Director, MicroPort India, said, “Cardiovascular diseases, especially Coronary Heart Disease (CHD), in India is an epidemic. So far, interventional cardiologists have been using Bare Metal Stents (BMS) or Drug Eluting Stents (DES) in patients but the availability of TES now adds to their choice of stent selection for better patient care.”
“The TES is approved in more than 26 countries for sale and is one of the most premium stents in the market.FIREHAWK is truly a generation beyond Drug Eluting Stent (DES) because of its innovative stent design with low load of bio-absorbable polymer and drug that is released only towards the vessel walls (smooth muscle cells),” added Dr Desai.
